• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名仅接受持续非卧床腹膜透析治疗的患者发生β2-微球蛋白淀粉样变。

Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.

作者信息

Jadoul M, Noel H, van Ypersele de Strihou C

机构信息

Department of Nephrology, University of Louvain Medical School, Cliniques Universitaires St-Luc, Brussels, Belgium.

出版信息

Am J Kidney Dis. 1990 Jan;15(1):86-8. doi: 10.1016/s0272-6386(12)80598-1.

DOI:10.1016/s0272-6386(12)80598-1
PMID:2403753
Abstract

The histological demonstration of beta 2-microglobulin (B2M) amyloidosis in a 75-year-old man treated exclusively by continuous ambulatory peritoneal dialysis (CAPD) for 87 months is reported. Amyloid deposits were detected in all joints from which synovial specimens were obtained at autopsy. It is of note that the patient had never undergone hemodialysis and had suffered only one episode of peritonitis. Both features are of interest, as the few reports of dialysis-related amyloidosis (DRA) in CAPD include patients who have been hemodialyzed and have suffered repeated episodes of peritonitis, both conditions being incriminated in the genesis of B2M amyloidosis. We conclude that DRA may develop in the absence of artificial membranes or frequent peritonitis episodes.

摘要

报道了一名75岁男性患者,仅接受持续非卧床腹膜透析(CAPD)治疗87个月,其β2微球蛋白(B2M)淀粉样变性的组织学表现。尸检时从所有获取滑膜标本的关节中均检测到淀粉样沉积物。值得注意的是,该患者从未接受过血液透析,仅发生过一次腹膜炎。这两个特征都很有意思,因为关于CAPD中与透析相关的淀粉样变性(DRA)的少数报道包括接受过血液透析且反复发生腹膜炎的患者,这两种情况都被认为与B2M淀粉样变性的发生有关。我们得出结论,在没有人工膜或频繁发生腹膜炎的情况下,也可能发生DRA。

相似文献

1
Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.一名仅接受持续非卧床腹膜透析治疗的患者发生β2-微球蛋白淀粉样变。
Am J Kidney Dis. 1990 Jan;15(1):86-8. doi: 10.1016/s0272-6386(12)80598-1.
2
Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD).一名长期持续非卧床腹膜透析(CAPD)患者的β2微球蛋白淀粉样变性
Perit Dial Int. 1989;9(4):321-4.
3
Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.与持续性非卧床腹膜透析相关的β2微球蛋白淀粉样变的临床、放射学及血清淀粉样蛋白P成分闪烁扫描特征
Nephrol Dial Transplant. 1999 Jun;14(6):1467-71. doi: 10.1093/ndt/14.6.1467.
4
Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.胸锁关节β2-微球蛋白淀粉样变性的组织学特征及其组织发生线索
Kidney Int. 1999 May;55(5):1983-90. doi: 10.1046/j.1523-1755.1999.00430.x.
5
Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.与血液透析患者相比,持续性非卧床腹膜透析(CAPD)患者组织学β2微球蛋白淀粉样变的患病率。
Kidney Int. 1998 Sep;54(3):956-9. doi: 10.1046/j.1523-1755.1998.00064.x.
6
Haemodialysis versus CAPD: equal predisposition to amyloidosis?血液透析与持续性非卧床腹膜透析:淀粉样变性的易感性相同吗?
Lancet. 1986 Apr 5;1(8484):795-6. doi: 10.1016/s0140-6736(86)91799-x.
7
Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.透析患者血清β2-微球蛋白浓度:内在肾功能的重要性。
J Lab Clin Med. 1994 Apr;123(4):495-505.
8
Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?持续非卧床腹膜透析与血液透析:淀粉样变性风险更低?
Nephrol Dial Transplant. 1988;3(3):291-4.
9
beta 2-Microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients.β2微球蛋白淀粉样变性。一种主要影响长期透析患者滑膜和骨骼的全身性淀粉样疾病。
Rheumatol Int. 1990;10(1):1-8. doi: 10.1007/BF02274774.
10
Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.在透析相关淀粉样变性中观察到的β2微球蛋白被晚期糖基化终产物修饰,这是由于尿毒症血清中积累的3-脱氧葡萄糖引起的。
Kidney Int. 1996 Mar;49(3):861-7. doi: 10.1038/ki.1996.119.